William P. Halford
Affiliations: | Molecular Biology Microbiology and Biochemistry | Southern Illinois University at Carbondale, Carbondale, IL |
Area:
Virology Biology, Molecular Biology, Cell BiologyGoogle:
"William Halford"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Royer DJ, Carr MM, Gurung HR, et al. (2017) The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa. Journal of Immunology (Baltimore, Md. : 1950) |
| Royer DJ, Carr MM, Chucair-Elliott AJ, et al. (2017) Impact of type 1 interferon on the safety and immunogenicity of an experimental live-attenuated herpes simplex virus type 1 vaccine in mice. Journal of Virology |
| Royer DJ, Gurung HR, Jinkins JK, et al. (2016) A Highly Efficacious HSV-1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology Via Humoral Immunity. Journal of Virology |
| Halford WP, Geltz J, Messer RJ, et al. (2015) Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2. Plos One. 10: e0145228 |
| Ariotti S, Beltman JB, Borsje R, et al. (2015) Subtle CXCR3-Dependent Chemotaxis of CTLs within Infected Tissue Allows Efficient Target Localization. Journal of Immunology (Baltimore, Md. : 1950). 195: 5285-95 |
| Gershburg S, Geltz J, Peterson KE, et al. (2015) The UL13 and US3 Protein Kinases of Herpes Simplex Virus 1 Cooperate to Promote the Assembly and Release of Mature, Infectious Virions. Plos One. 10: e0131420 |
| Chambers CB, Halford WP, Geltz J, et al. (2015) A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter. Plos One. 10: e0122253 |
| Geltz JJ, Gershburg E, Halford WP. (2015) Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine. Plos One. 10: e0116091 |
| Halford WP. (2014) Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines? Expert Review of Vaccines. 13: 691-710 |
| Workenhe ST, Simmons G, Pol JG, et al. (2014) Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 123-31 |